Diabetes

News

Lilly unveils promising data from dual-action diabetes drug

Eli Lilly’s investigational diabetes drug has shown early promise as a possible aid to overcoming obesity in trial results announced this week.

News

Novo to market 'connected' insulin pens next year

Novo Nordisk is to launch “connected” insulin pens, responding for demands from patients for devices able to communicate with glucose monitoring systems and glucose meters.

News

Roche buys Tusk, plus cancer immunotherapy drug, for £62m

Roche has bought immuno-oncology biotech firm Tusk Therapeutics for an upfront payment of £62 million.

News

Roche Ieso digital health therapeutics mental health

Roche Diabetes Care partners with digital therapeutics firm ...

Roche’s diabetes arm is working with Ieso Digital Health to test the Cambridge, UK-based digital therapeutics firm’s mental health programme in type 2 diabetes patients in the UK and Irelan

News

Study shows AZ's Farxiga diabetes drug cuts heart risks

AstraZeneca’s Farxiga has become the latest type 2 diabetes drug to show it can reduce cardiovascular risk in a clinical trial.

News

Novo Nordisk lays off 400 staff in R&D shake-up

Novo Nordisk is laying off 400 people in Denmark and China so it can overhaul its R&D and speed up the expansion and diversification of products for serious chronic diseases.

Lilly unveils promising data from dual-action diabetes drug

Novo to market 'connected' insulin pens next year

Roche buys Tusk, plus cancer immunotherapy drug, for £62m

Roche Diabetes Care partners with digital therapeutics firm ...

Study shows AZ's Farxiga diabetes drug cuts heart risks

Novo Nordisk lays off 400 staff in R&D shake-up

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Diabetes

Editor's Picks